The newly formed SPAC in an S-1 filing said it will offer 10 million units at $10 each to raise $100 million.
Omega Alpha intend to focus on the healthcare or healthcare-related industries. “In particular, we expect to target North American or European companies in the biotechnology sector where our management team has extensive investment experience,” the SPAC noted in the filing.
The SPAC intends to list on the Nasdaq under OMEG. Read more.
